Stock & Company Details
Aytu BioPharma Inc $AYTU
Price:
N/A
N/A
11M
$21M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.33
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Consumer Services
AYTU technical indicators
Latest Aytu BioPharma Inc (AYTU) indicator readings as of 2026-10-29.
AYTU's 14-day RSI is 46.0, in neutral territory. At $1.98 it is trading 14.7% below its 200-day moving average of $2.32, and below its 50-day average of $2.11. Price sits in the middle of its Bollinger Bands ($1.89 to $2.09). ADX reads 18.6, indicating a range-bound market rather than a trend.
Overview
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.
Finance Bot
Ask your questions
Start by typing a question below.
